Get the Stockscreener App
5.65
0.35%
-0.02
After Hours:
5.70
0.05
+0.88%
Reshape Lifesciences Inc stock is traded at $5.65, with a volume of 92,358.
It is down -0.35% in the last 24 hours and down -39.49% over the past month.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
See More
Previous Close:
$5.67
Open:
$5.58
24h Volume:
92,358
Relative Volume:
0.59
Market Cap:
$2.85M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.0882
EPS:
-64.04
Net Cash Flow:
$-17.45M
1W Performance:
-29.29%
1M Performance:
-39.49%
6M Performance:
-47.17%
1Y Performance:
-71.18%
1-Day Range:
$5.39
$6.05
1-Week Range:
$5.39
$7.49
52-Week Range:
$5.0313
$34.22
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Name
Reshape Lifesciences Inc
Sector
Industry
Phone
949-429-6680
Address
1001 CALLE AMANECER, SAN CLEMENTE
Reshape Lifesciences Inc Stock (RSLS) Latest News
Trend Tracker for (RSLS) - Stock Traders Daily
Gastric Balloon Procedures Market Insights and Growth - openPR
A new trading data show ReShape Lifesciences Inc. (RSLS) is showing positive returns. - SETE News
RELX PLC Continues Share Buyback Strategy - TipRanks
The ReShape Lifesciences Inc. (RSLS) had a good session last reading, didn’t it? - US Post News
In the Green: Relay Therapeutics Inc (RLAY) Closes at 7.50, Up/Down -4.58 from Previous Day - The Dwinnex
Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested - Yahoo Finance
REE Automotive Kick-Off U.S. Production With Roush Industries as Contract Manufacturer - StockTitan
Insider’s View: Deciphering ReShape Lifesciences Inc. (RSLS)’s Financial Health Through Ratios - The Dwinnex
ReShape Lifesciences Inc.’s Shares Reel: -42.65% Quarterly Revenue Decline Amid 3.29M Market Cap - The InvestChronicle
Respiri Limited Boosts Patient Care with New Agreements - TipRanks
Rubric Capital Management LP Increases Stock Position in ReNew Energy Global Plc (NASDAQ:RNW) - Defense World
ReShape Lifesciences (NASDAQ:RSLS) Shares to Reverse Split on Monday, September 23rd - Defense World
ReShape Lifesciences announces 1-for-58 reverse stock split - Investing.com
ReShape Lifesciences Inc. (RSLS) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
RSLS stock touches 52-week low at $0.14 amid market challenges By Investing.com - Investing.com South Africa
ReShape Lifesciences announces 1-for-58 reverse stock split By Investing.com - Investing.com South Africa
ReShape Lifesciences announces 1-for-58 reverse stock split By Investing.com - Investing.com Australia
RSLS stock touches 52-week low at $0.14 amid market challenges - Investing.com Canada
Take off with ReShape Lifesciences Inc. (RSLS): Get ready for trading - SETE News
Ratios Reveal: Breaking Down ReShape Lifesciences Inc. (RSLS)’s Financial Health - The Dwinnex
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split - GlobeNewswire
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split - StockTitan
RSLS stock touches 52-week low at $0.14 amid market challenges - Investing.com
Recent Insider Activity Suggests Potential Gains for ReShape Lifesciences Inc. (RSLS) - Knox Daily
The Potential Rise in the Price of Symbotic Inc (SYM) following insiders activity - Knox Daily
These Numbers Prove Just How Vibrant The ASML Holding NV (NASDAQ: ASML) Stock Has Been - Stocks Register
United States Minimally Invasive Bariatric Surgery Device Market By Application - North America Agile Program ...
This Data Shows Just How Strong Catheter Precision Inc. (AMEX: VTAK) Stock Is - Stocks Register
American Airlines Group Inc (AAL) receives a Mkt perform rating from Bernstein - Knox Daily
If You Don’t Buy Mira Pharmaceuticals Inc (NASDAQ: MIRA) Now, You’ll Regret It Later - Stocks Register
Athira Pharma Inc (NASDAQ: ATHA): Slumped -75.09% In 2024, Outlook Stable - Stocks Register
Is Windtree Therapeutics Inc’s (NASDAQ:WINT) Stock On The Decline? - Stocks Register
Faraday Future Intelligent Electric Inc’s (NASDAQ: FFIE) Stock Price Continues To Fall - Stocks Register
How to interpret ReShape Lifesciences Inc. (RSLS)’s stock chart patterns - US Post News
Are Value Hunters Buying Bionano Genomics Inc (NASDAQ: BNGO) Stock? - Stocks Register
Would I Buy Public Service Enterprise Group Inc. (NYSE: PEG) Stock At Any Time In The Future? - Stocks Register
Citigroup Downgrades Krystal Biotech Inc (KRYS) to a Neutral from a Buy - Knox Daily
Synthetic Biosensors Market: Emerging Trends and Growth Prospects (2024-2031) - WhaTech
Analyzing Neuromodulation Market Evolution: Industry Size, Share, and Future Growth Forecast for 2024-2032 - openPR
Focus Universal Inc (FCUV) Becoming More Attractive for Investors - Knox Daily
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2024 Earnings Call Transcript - MSN
Gastric Balloon Market Estimated to Experience a Hike in Growth by 2027 - openPR
Gastric Balloon Procedures Market Report Analysis, Research - openPR
Rocket Lab USA Inc [RKLB] Records 50-Day SMA of $5.48 - Knox Daily
Market Insights: ReShape Lifesciences Inc. (RSLS)’s Notable Gain of 0.19, Closing at 0.16 - The Dwinnex
Was there any good news for ReShape Lifesciences Inc. (RSLS) stock in the last session? - US Post News
A Guide To The Risks Of Investing In Lancaster Colony Corp. (LANC) - Knox Daily
Bariatric Surgical Devices Market to Grow by USD 588.8 Million (2024-2028) as Medical Tourism Boosts Revenue, AI's Role in Market Transformation- Technavio Report - The Malaysian Reserve
Bariatric Surgical Devices Market To Grow By USD 588.8 Million (2024-2028) As Medical Tourism Boosts Revenue, AI's Role In Market Transformation- Tech... - MENAFN.COM
Bariatric Surgical Devices Market to Grow by USD 588.8 Million (2024-2028) as Medical Tourism Boosts Revenue, AI's Role in Market Transformation- Technavio Report - PR Newswire
Reshape Lifesciences Inc Stock (RSLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):